• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Blood transfusion services amidst the COVID-19 pandemic.

作者信息

Noordin Siti Salmah, Yusoff Narazah Mohd, Karim Faraizah Abdul, Chong Soon Eu

机构信息

Cluster of Regenerative Medicine, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Kepala Batas, Malaysia.

Hemophilia Clinic, National Blood Centre, Kuala Lumpur, Malaysia.

出版信息

J Glob Health. 2021 Apr 17;11:03053. doi: 10.7189/jogh.11.03053.

DOI:10.7189/jogh.11.03053
PMID:33884188
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8053396/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a56e/8053396/5c224ce21129/jogh-11-03053-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a56e/8053396/dd2e86eb01d4/jogh-11-03053-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a56e/8053396/1ed8255c8ff3/jogh-11-03053-Fa.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a56e/8053396/1cadda84097a/jogh-11-03053-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a56e/8053396/5c224ce21129/jogh-11-03053-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a56e/8053396/dd2e86eb01d4/jogh-11-03053-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a56e/8053396/1ed8255c8ff3/jogh-11-03053-Fa.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a56e/8053396/1cadda84097a/jogh-11-03053-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a56e/8053396/5c224ce21129/jogh-11-03053-F3.jpg

相似文献

1
Blood transfusion services amidst the COVID-19 pandemic.新冠疫情期间的输血服务
J Glob Health. 2021 Apr 17;11:03053. doi: 10.7189/jogh.11.03053.
2
Transfusion services operations during the COVID-19 pandemic: Results from AABB survey.新冠疫情期间的输血服务运营：美国血库协会调查结果
Transfusion. 2020 Nov;60(11):2760-2762. doi: 10.1111/trf.15986.
3
Blood shortages planning in Canada: The National Emergency Blood Management Committee experience during the first 6 months of the COVID-19 pandemic.加拿大的血液短缺规划：国家紧急血液管理委员会在新冠疫情头6个月的经历
Transfusion. 2021 Nov;61(11):3258-3266. doi: 10.1111/trf.16661. Epub 2021 Sep 13.
4
Blood Banking and Transfusion Medicine Challenges During the COVID-19 Pandemic.新冠疫情期间的血液库与输血医学挑战
Clin Lab Med. 2020 Dec;40(4):587-601. doi: 10.1016/j.cll.2020.08.013. Epub 2020 Aug 8.
5
Current and emerging infectious risks of blood transfusions.输血当前及新出现的感染风险。
JAMA. 2003 Feb 26;289(8):959-62. doi: 10.1001/jama.289.8.959.
6
The impact of COVID-19 pandemic on blood supplies and transfusion services in Eastern Mediterranean Region.COVID-19 大流行对东地中海区域血液供应和输血服务的影响。
Transfus Clin Biol. 2021 Feb;28(1):16-24. doi: 10.1016/j.tracli.2020.11.002. Epub 2020 Dec 1.
7
A critical shortage.
Tex Med. 2000 Jul;96(7):36-42.
8
[Sufficient national supply of all blood products--a pressing goal].[实现全国所有血液制品的充足供应——一个紧迫的目标]
Lakartidningen. 1990 Oct 3;87(40):3193-5.
9
A bloody mess. New safeguards will cut supplies of a lifesaving resource.一片混乱。新的保障措施将削减一种救命资源的供应。
US News World Rep. 2001 Sep 3;131(8):36-9.
10
Impact of COVID-19 in the attendance of blood donors and production on a Brazilian Blood Centres.COVID-19 对巴西血站献血者出勤率和采血量的影响。
Transfus Med. 2021 Jun;31(3):206-212. doi: 10.1111/tme.12733. Epub 2020 Oct 28.

引用本文的文献

1
Exploring the Therapeutic Potential of L. Phytochemicals: A Computational Study on Inhibiting SARS-CoV-2's Main Protease (Mpro).探讨 L. 植物化学物质的治疗潜力：抑制 SARS-CoV-2 主要蛋白酶（Mpro）的计算研究。
Molecules. 2024 May 27;29(11):2524. doi: 10.3390/molecules29112524.
2
The Impact of COVID-19 Pandemic on Blood Transfusion Services: A Perspective from Health Professionals and Donors.新冠疫情对输血服务的影响：来自卫生专业人员和献血者的视角
J Multidiscip Healthc. 2021 Nov 2;14:3063-3071. doi: 10.2147/JMDH.S337039. eCollection 2021.

本文引用的文献

1
The Impact of COVID-19 on Organ Donation, Procurement, and Liver Transplantation in the United States.2019年冠状病毒病对美国器官捐赠、获取及肝移植的影响
Hepatol Commun. 2020 Oct 18;5(1):5-11. doi: 10.1002/hep4.1620. eCollection 2021 Jan.
2
COVID-19 in Health-Care Workers: A Living Systematic Review and Meta-Analysis of Prevalence, Risk Factors, Clinical Characteristics, and Outcomes.医护人员中的 COVID-19：一项针对患病率、风险因素、临床特征和结局的实时系统评价和荟萃分析。
Am J Epidemiol. 2021 Jan 4;190(1):161-175. doi: 10.1093/aje/kwaa191.
3
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
新冠康复者血浆或高效免疫球蛋白用于新冠患者：一项实时系统评价
Cochrane Database Syst Rev. 2020 Jul 10;7(7):CD013600. doi: 10.1002/14651858.CD013600.pub2.
4
Blood transfusion utilization in hospitalized COVID-19 patients.住院 COVID-19 患者的输血利用情况。
Transfusion. 2020 Sep;60(9):1919-1923. doi: 10.1111/trf.15947. Epub 2020 Jul 4.
5
Pathogen reduction of SARS-CoV-2 virus in plasma and whole blood using riboflavin and UV light.利用核黄素和紫外线对血浆和全血中的 SARS-CoV-2 病毒进行减毒处理。
PLoS One. 2020 May 29;15(5):e0233947. doi: 10.1371/journal.pone.0233947. eCollection 2020.
6
Estimation of the number of blood donors during the COVID-19 incubation period across China and analysis of prevention and control measures for blood transfusion transmission.估算中国 COVID-19 潜伏期的献血者人数，并分析预防和控制输血传播的措施。
Transfusion. 2020 Aug;60(8):1778-1784. doi: 10.1111/trf.15858. Epub 2020 May 22.
7
COVID-19: Universal health coverage now more than ever.2019冠状病毒病：全民健康覆盖现在比以往任何时候都更加重要。
J Glob Health. 2020 Jun;10(1):010350. doi: 10.7189/jogh.10.010350.
8
COVID-19 transmission and blood transfusion: A case report.COVID-19 传播与输血：病例报告。
J Infect Public Health. 2020 Nov;13(11):1678-1679. doi: 10.1016/j.jiph.2020.05.001. Epub 2020 May 13.
9
The blood supply management amid the COVID-19 outbreak.新冠疫情期间的血液供应管理
Transfus Clin Biol. 2020 Aug;27(3):147-151. doi: 10.1016/j.tracli.2020.04.002. Epub 2020 Apr 25.
10
Convalescent plasma in Covid-19: Possible mechanisms of action.恢复期血浆治疗 COVID-19：可能的作用机制。
Autoimmun Rev. 2020 Jul;19(7):102554. doi: 10.1016/j.autrev.2020.102554. Epub 2020 May 5.